Who owns AKTS
69 institutions reported holding AKTS for 2026Q1, together 71% of the company.
69
Institutions reporting a position · as of 2026Q1
- Shares held by institutions
- 34.7M
Shares held by institutions · 71% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $621M
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 35%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 1
- New positions
- 66
- Positions exited
- 0
- Added to
- 0
- Reduced
- 0
- Top 10 holdersof the company
- 52%
| Holder | Shares | % of company | Value |
|---|---|---|---|
| MPM BIOIMPACT LLC | 4.8M | 9.9% | $87M |
| EcoR1 Capital, LLC | 4.8M | 9.9% | $86M |
| Blue Owl Capital Holdings LP | 3.2M | 6.5% | $57M |
| WELLINGTON MANAGEMENT GROUP LLP | 2.3M | 4.8% | $41M |
| T. Rowe Price Investment Management, Inc. | 2.1M | 4.4% | $38M |
| BlackRock Inc. | 2.1M | 4.3% | $38M |
| RTW INVESTMENTS, LP | 1.6M | 3.3% | $28M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.6M | 3.2% | $28M |
| RA CAPITAL MANAGEMENT, L.P. | 1.5M | 3.1% | $27M |
| HENDERSON GROUP PLC | 1.5M | 3.0% | $26M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Biotechnology
Ranks #52 of 145 by Smart Score